Impact Forecasts Cloudy

Current models do a poor job of predicting the impact individual scientists will have, according to a study.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, DANIEL WEHNERWhen a hiring committee or a grant study section evaluates a candidate, it must look at past achievements as a predictor of future success. In addition to other metrics, these groups are increasingly using the h-index, which is a score calculated based on one’s publication and citation records. But researchers from Aalto University School of Science in Finland and the IMT Institute for Advanced Studies in Italy have shown that models based on the h-index are flawed, and that they do a poor job of predicting the impact that a scientist will have in the future. Their work was published this week (October 29) in Scientific Reports.

The researchers used publication and citation data from 476 physicists, 236 cell biologists, and 50 mathematicians and also calculated those researchers’ h-indices. By comparing these three metrics, they showed that for each, “the correlation between past and future is similar,” the researchers wrote. “Thus our analysis suggests that all these measures are equally good (or equally bad) in predicting future impact,” they concluded. The researchers also showed that “predictive power” of the h-index did not predict the impact of early career researchers well. Because the h-index is cumulative, if it was high early on in a scientist’s career, it was also likely to be high later. Though there may be a correlation between early and later success, the authors wrote that it “will require a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies